danielle ward mason Doctors abandoning Invokana over increased risk of amputationsInvokana was approved by the Food and Drug Administration (FDA) in 2013 as the first SGLT2 inhibitor to help lower blood sugar in adults with Type 2 diabetes, as Beasley Allen has previously explained. However, the drug, manufactured by Johnson and Johnson’s Janssen Pharmaceuticals, has been plagued with a number of reported adverse side effects.

Among these, Invokana has been linked to diabetic ketoacidosis (DKA), or kidney damage caused from the buildup of too much acid in the blood, as well as the risk of serious urinary tract infections (UTIs). These UTIs can lead to a serious blood infection called urosepsis or kidney infection called pyelonephritis, according to Righting Injustice.

But the latest reported adverse side effect connected to the medication – an increased risk of amputation – has led some doctors to stop prescribing Invokana.

Doctors across the country “are scurrying to take patients off of the diabetes drug canagliflozin (Invokana)” said Medpage Today. The proactive measures come after the results of a FDA-mandated clinical trial showed the drug doubled the risk of leg and foot amputations compared with outcomes of patients taking a placebo. Beasley Allen previously explained that the dangers are even present in patients without risk factors for amputation.

The U.S. Judicial Panel on Multidistrict Litigation reports that more than 740 lawsuits have been filed in the multidistrict litigation (MDL) against Janssen Pharmaceuticals – more than 13 times the number of lawsuits originally consolidated in the U.S. District Court for New Jersey with Judge Brian R. Martinotti presiding. The claims allege the drugmaker failed to properly test Invokana and warn of the risks and consequences of using the Type 2 diabetes drug.

* * *

Lawyers in Beasley Allen’s Mass Torts Section are investigating claims on behalf of individuals and families injured by Invokana and Invokamet, specifically cases involving DKA, acute kidney injury, heart attack and stroke. If you would like more information, contact Danielle Ward Mason, a lawyer in our Mass Torts Section. She can be reached at 800-898-2034 or by email at Danielle.Mason@beasleyallen.com.

Sources:
Beasley Allen
Righting Injustice
Medpage Today
U.S. Judicial Panel on Multidistrict Litigation



We're here to help!

We live by our creed of "helping those who need it most" and have helped thousands of clients get the justice they desperately needed and deserved. If you feel you have a case or just have questions please contact us for a free consultation. There is no risk and no fees unless we win for you.

Fields marked    may be required for submission.
  1. I'm an attorney

Number of Invokana MDL lawsuits grows

In less than a year, the number of lawsuits consolidated under the Invokana Multidistrict Litigation...

Concern over Invokana adverse side effects continues...

Reports of amputations connected to canagliflozin, the key ingredient in brand name medications Invokana...
Danielle Ward-Mason

Beasley Allen's Danielle Ward Mason named to Law360...

The Law360 Rising Stars designation recognizes attorneys younger than 40 who excel in their profession.

Invokana clinical trial shows drug doubles risk of...

Jansen reported Invokana reduced the risk of cardiovascular complications in diabetic patients, but it...

J&J and Jansen Pharmaceuticals look to expand uses for...

Researchers have tracked additional data about patients’ renal outcomes as a result of Invokana's link...
Danielle Ward-Mason

Beasley Allen lawyer Danielle Mason selected to help...

Danielle Ward Mason, the firm’s leading Invokana attorney, has been appointed to serve on the...

Continuing the battle with Big Pharma

The entire Beasley Allen staff had our personal interest at heart. We were part of the family of a down to earth, trustworthy, understanding law firm. Thank you, Beasley Allen, for continuing the battle with Big Pharma.

—Richard